Výsledky vyhledávání - "Joan Antoni Vallés"

Akademický článek

Cardiovascular and mortality benefits of sodium–glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus: CVD-Real Catalonia

Autor: Jordi Real, Bogdan Vlacho, Emilio Ortega, Joan Antoni Vallés, Manel Mata-Cases, Esmeralda Castelblanco, Eric T. Wittbrodt, Peter Fenici, Mikhail Kosiborod, Dídac Mauricio, Josep Franch-Nadal

Publikováno v: Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-11 (2021)

Abstract Background Evidence from prospective cardiovascular (CV) outcome trials in type 2 diabetes (T2DM) patients supports the use of sodium–glucose co-transporter-2 inhibitors (SGLT2i) to reduce the risk of CV events. In this study, we compared

Externí odkaz: https://doaj.org/article/a7e7ad8919684a4ebb9ce7e799f82d86

Zobrazit plný text záznamu

Cumplimiento de las recomendaciones de ajuste de la dosis de inhibidores DPP4 según la función renal en una base de datos poblacional

Autor: Bogdan Vlacho, Jordi Real, Emilio Ortega, Manel Mata-Cases, Joan Antoni Vallés, Didac Mauricio, Josep Franch-Nadal

Publikováno v: Endocrinología, Diabetes y Nutrición. 69:83-91

Resumen Objetivo Examinar el patron de prescripcion de los distintos inhibidores de la dipeptidil-peptidasa 4 (iDPP4) en funcion del filtrado glomerular estimado (FGe) en condiciones de practica clinica real. Metodologia Estudio descriptivo observaci

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::538f4823707102771d2d3b4f05e83247
https://doi.org/10.1016/j.endinu.2021.01.013

Zobrazit plný text záznamu

Cardiovascular and mortality benefits of sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus: CVD-Real Catalonia

Autor: Emilio Ortega, Josep Franch-Nadal, Esmeralda Castelblanco, Didac Mauricio, Bogdan Vlacho, Mikhail Kosiborod, Eric Wittbrodt, Peter Fenici, Jordi Real, Manel Mata-Cases, Joan Antoni Vallés

Publikováno v: Cardiovascular Diabetology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-11 (2021)

Background Evidence from prospective cardiovascular (CV) outcome trials in type 2 diabetes (T2DM) patients supports the use of sodium–glucose co-transporter-2 inhibitors (SGLT2i) to reduce the risk of CV events. In this study, we compared the risk

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38325dfd280fef51822367b698968cfc
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=5052

Zobrazit plný text záznamu

Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes: Prescription According to Reimbursement Constraints and Guideline Recommendations in Catalonia

Autor: Bogdan Vlacho, Emilio Ortega, Didac Mauricio, Manel Mata-Cases, Mònica Gratacòs, Jordi Real, Josep Franch-Nadal, Joan Antoni Vallés

Publikováno v: Journal of Clinical Medicine
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Volume 8
Issue 9
Journal of Clinical Medicine, Vol 8, Iss 9, p 1389 (2019)

To assess the clinical characteristics, the prescription pattern of GLP-1 receptor agonists (GLP-1RA) users, and HbA1c and weight change, we retrospectively assessed patients with type 2 diabetes by initiating GLP-1RA as an add-on to the standard of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e758f64ac995f85c326f887b9add07f1
https://pubmed.ncbi.nlm.nih.gov/31491916

Zobrazit plný text záznamu

Plný text ve formátu HTML

Use of heparin for the prevention of venous thromboembolism

Autor: Antoni Vallano, J. M. Arnau, Joan‐Antoni Vallés, Rosa Maria Gracia, Joan-Ramon Laporte, Salvador Duran

Publikováno v: Pharmacoepidemiology & Drug Safety. 3:211-214

The value of heparin in the prevention of venous thromboembolism has been shown effective and safe by controlled studies. However, how these studies have influenced physicians' decisions in thrombo-prophylaxis is not known. With the aim of evaluating

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::af063ebccca217297a57ca75870ecc91
https://doi.org/10.1002/pds.2630030406

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání